Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Eiko Lifesciences FCF Yield % Related Terms
Eiko Lifesciences FCF Yield % Historical Data
* Premium members only.
The historical data trend for Eiko Lifesciences's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540204 vs LIN, SHW, ECL: FCF Yield % Comparison
For the Specialty Chemicals subindustry, Eiko Lifesciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiko Lifesciences FCF Yield % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Eiko Lifesciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Eiko Lifesciences's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiko Lifesciences (BOM:540204) has a FCF Yield % of 3.38 as of Aug. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Eiko Lifesciences and its competitors. According to the industry distribution chart, Eiko Lifesciences ranks #581 out of 1609 companies in the Chemicals industry, placing it in the top 36.1%.
Is Eiko Lifesciences' FCF Yield % too high?
Eiko Lifesciences' current FCF Yield % is 3.38. The Chemicals industry median FCF Yield % is 1.14. Eiko Lifesciences' value of 3.38 is 196.5% above this industry median. Based on the distribution chart, Eiko Lifesciences ranks #581 out of 1609 companies in the Chemicals industry, which is above the industry midpoint. Overall, Eiko Lifesciences has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eiko Lifesciences' FCF Yield % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Eiko Lifesciences ranks #581 out of 1609 companies for FCF Yield %. This puts Eiko Lifesciences in the upper half of its industry. The industry median FCF Yield % is 1.14. Eiko Lifesciences' value of 3.38 is 196.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Chemicals company?
The median FCF Yield % among Chemicals companies is 1.14, based on 1,609 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiko Lifesciences's current FCF Yield % of 3.38 is 196.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Eiko Lifesciences and its competitors. For the Chemicals industry, the median FCF Yield % is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiko Lifesciences's current FCF Yield % is 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiko Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Eiko Lifesciences (BOM:540204) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹80.80, compared to a current price of ₹46.65 — trading 42.3% below its estimated fair value. The current FCF Yield % is 3.38 and 196.5% above the Chemicals industry median of 1.14. Eiko Lifesciences' overall GF Score™ is 66/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Eiko Lifesciences (BOM:540204), the current FCF Yield % is 3.38 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiko Lifesciences (BOM:540204) Overvalued in 2026?
Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued.
The current stock price of ₹46.65 is trading 42.3% below its estimated GF Value™ of ₹80.80.
GuruFocus considers Eiko Lifesciences to be Significantly Undervalued.
Key valuation signals for BOM:540204:
FCF Yield %: 3.38
GF Value™: ₹80.80 vs. price of ₹46.65 (42.3% below fair value)
Industry Position: 196.5% above the Chemicals median (#581 of 1609)
No single metric tells the full story. See the BOM:540204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
66GF Score
Get the complete analysis for BOM:540204
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540204 has been successfully added to your 
